Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.
作者信息
Brown M S, Goldstein J L
出版信息
J Clin Invest. 1983 Sep;72(3):743-7. doi: 10.1172/JCI111044.
Abstract
摘要
相似文献
1
Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.肝脏中的脂蛋白受体。血浆胆固醇转运的控制信号。
J Clin Invest. 1983 Sep;72(3):743-7. doi: 10.1172/JCI111044.
2
Genetic mutations affecting human lipoprotein metabolism.影响人类脂蛋白代谢的基因突变。
Adv Hum Genet. 1985;14:125-215, 383-6. doi: 10.1007/978-1-4615-9400-0_3.
3
Regulation of plasma cholesterol by lipoprotein receptors.脂蛋白受体对血浆胆固醇的调节。
Science. 1981 May 8;212(4495):628-35. doi: 10.1126/science.6261329.
4
Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia.有缺陷的脂蛋白受体与动脉粥样硬化。家族性高胆固醇血症动物模型的启示。
N Engl J Med. 1983 Aug 4;309(5):288-96. doi: 10.1056/NEJM198308043090507.
5
Characterization of a human hepatic receptor for high density lipoproteins.人高密度脂蛋白肝脏受体的特性研究
Arteriosclerosis. 1985 May-Jun;5(3):228-37. doi: 10.1161/01.atv.5.3.228.
6
Regulation of LDL receptors in vivo.体内低密度脂蛋白受体的调节
Agents Actions Suppl. 1984;16:191-203. doi: 10.1007/978-3-0348-7235-5_22.
7
The low density lipoprotein receptor pathway in animals and man.动物和人类中的低密度脂蛋白受体途径。
Health Bull (Edinb). 1982 Jul;40(4):197-205.
8
Role of the liver in the degradation of lipoproteins.肝脏在脂蛋白降解中的作用。
Gastroenterology. 1985 Jan;88(1 Pt 1):192-205. doi: 10.1016/s0016-5085(85)80155-4.
9
Distinct hepatic receptors for low density lipoprotein and apolipoprotein E in humans.
Science. 1985 Feb 15;227(4688):759-61. doi: 10.1126/science.2982214.
10
The metabolic basis of familial hypercholesterolemia.家族性高胆固醇血症的代谢基础。
Klin Wochenschr. 1983 Apr 15;61(8):383-401. doi: 10.1007/BF01488153.
引用本文的文献
1
Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes.脂质化的载脂蛋白E（ApoE）与受体的相互作用减少，可保护细胞免受ApoE及其溶酶体中脂质成分致病性的影响。
Cell. 2025 Jan 9;188(1):187-206.e26. doi: 10.1016/j.cell.2024.10.027. Epub 2024 Nov 11.
2
Impact of Quantity and Type of Dietary Protein on Cardiovascular Disease Risk Factors Using Standard and Network Meta-analyses of Randomized Controlled Trials.利用随机对照试验的标准和网状荟萃分析评估膳食蛋白质的数量和类型对心血管疾病风险因素的影响
Nutr Rev. 2025 Mar 1;83(3):e814-e828. doi: 10.1093/nutrit/nuae086.
3
Effect of different forms of coconut on the lipid profile in normal free-living healthy subjects: A randomized controlled trial (Phase II).不同形式的椰子对正常自由生活的健康受试者血脂水平的影响：一项随机对照试验（II期）。
Glob Epidemiol. 2024 Feb 2;7:100138. doi: 10.1016/j.gloepi.2024.100138. eCollection 2024 Jun.
4
The Immunosuppressive Potential of Cholesterol Sulfate Through T Cell Microvilli Disruption.胆固醇硫酸酯通过破坏T细胞微绒毛发挥免疫抑制作用。
Immune Netw. 2023 Jun 15;23(3):e29. doi: 10.4110/in.2023.23.e29. eCollection 2023 Jun.
5
Modifiable cardiovascular risk factors and genetics for targeted prevention of dementia.可改变的心血管危险因素和遗传学在痴呆症的靶向预防中的作用。
Eur Heart J. 2023 Jul 21;44(28):2526-2543. doi: 10.1093/eurheartj/ehad293.
6
Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment.基于同时质谱的载脂蛋白谱分析及 ASCVD 和轻度认知障碍患者载脂蛋白 E 表型分析。
Nutrients. 2022 Jun 15;14(12):2474. doi: 10.3390/nu14122474.
7
Cholesterol in the Cell Membrane-An Emerging Player in Atherogenesis.细胞膜中的胆固醇——动脉粥样硬化形成中的一个新兴角色。
Int J Mol Sci. 2022 Jan 4;23(1):533. doi: 10.3390/ijms23010533.
8
Lactobacillus mediates the expression of NPC1L1, CYP7A1, and ABCG5 genes to regulate cholesterol.乳酸杆菌介导NPC1L1、CYP7A1和ABCG5基因的表达以调节胆固醇。
Food Sci Nutr. 2021 Sep 30;9(12):6882-6891. doi: 10.1002/fsn3.2600. eCollection 2021 Dec.
9
Mechanism-Based Biomarker Prediction for Low-Grade Inflammation in Liver and Adipose Tissue.基于机制的肝脏和脂肪组织低度炎症生物标志物预测
Front Physiol. 2021 Nov 10;12:703370. doi: 10.3389/fphys.2021.703370. eCollection 2021.
10
Flavonoids and Their Metabolites: Prevention in Cardiovascular Diseases and Diabetes.黄酮类化合物及其代谢产物：对心血管疾病和糖尿病的预防作用
Diseases. 2017 Sep 5;5(3):19. doi: 10.3390/diseases5030019.
本文引用的文献
1
Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia.一个大家系中异载脂蛋白E表型的遗传传递：与异常β脂蛋白血症和高脂血症的关系。
Metabolism. 1981 Jan;30(1):79-88. doi: 10.1016/0026-0495(81)90223-7.
2
Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E.III型高脂蛋白血症：异常载脂蛋白E的代谢缺陷。
Science. 1981 Feb 6;211(4482):584-6. doi: 10.1126/science.7455696.
3
Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus.胆固醇诱导的主要含载脂蛋白E的高密度脂蛋白与低密度脂蛋白受体位点发生突变的培养成纤维细胞的受体结合。
Biochemistry. 1980 Sep 2;19(18):4359-65. doi: 10.1021/bi00559a032.
4
Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat.大鼠肝脏对富含甘油三酯的脂蛋白及其残粒摄取的决定因素。
J Biol Chem. 1980 Jun 10;255(11):5475-80.
5
Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism.消胆胺促进受体介导的低密度脂蛋白分解代谢。
N Engl J Med. 1980 May 29;302(22):1219-22. doi: 10.1056/NEJM198005293022202.
6
7
Human apolipoprotein E. The complete amino acid sequence.人载脂蛋白E。完整氨基酸序列。
J Biol Chem. 1982 Apr 25;257(8):4171-8.
8
Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.在WHHL兔中，极低密度脂蛋白和中间密度脂蛋白清除延迟，向低密度脂蛋白的转化增强。
Proc Natl Acad Sci U S A. 1982 Sep;79(18):5693-7. doi: 10.1073/pnas.79.18.5693.
9
Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of familial dysbetalipoproteinemia.载脂蛋白E肝脏摄取中的同蛋白特异性与家族性异常β脂蛋白血症的发病机制
Proc Natl Acad Sci U S A. 1980 Jul;77(7):4349-53. doi: 10.1073/pnas.77.7.4349.
10
Characterization of chylomicron remnant binding to rat liver membranes.乳糜微粒残粒与大鼠肝细胞膜结合的特性研究
J Lipid Res. 1982 Jan;23(1):42-52.
Zotero 插件